<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Vidula MK</submitter><funding>NCATS NIH HHS</funding><funding>NHLBI NIH HHS</funding><pagination>609-624</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9833283</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>16(5)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Myocardial injury in patients with COVID-19 and suspected cardiac involvement is not well understood.&lt;h4>Objectives&lt;/h4>The purpose of this study was to characterize myocardial injury in a multicenter cohort of patients with COVID-19 and suspected cardiac involvement referred for cardiac magnetic resonance (CMR).&lt;h4>Methods&lt;/h4>This retrospective study consisted of 1,047 patients from 18 international sites with polymerase chain reaction-confirmed COVID-19 infection who underwent CMR. Myocardial injury was characterized as acute myocarditis, nonacute/nonischemic, acute ischemic, and nonacute/ischemic patterns on CMR.&lt;h4>Results&lt;/h4>In this cohort, 20.9% of patients had nonischemic injury patterns (acute myocarditis: 7.9%; nonacute/nonischemic: 13.0%), and 6.7% of patient</pubmed_abstract><journal>JACC. Cardiovascular imaging</journal><pubmed_title>Myocardial Injury on CMR in Patients With COVID-19 and Suspected Cardiac Involvement.</pubmed_title><pmcid>PMC9833283</pmcid><funding_grant_id>R01 HL148103</funding_grant_id><funding_grant_id>UL1 TR001863</funding_grant_id><pubmed_authors>Lambers M</pubmed_authors><pubmed_authors>Tong MS</pubmed_authors><pubmed_authors>Mei W</pubmed_authors><pubmed_authors>Kwan JM</pubmed_authors><pubmed_authors>Vidula MK</pubmed_authors><pubmed_authors>Pyda M</pubmed_authors><pubmed_authors>Elliott M</pubmed_authors><pubmed_authors>Han Y</pubmed_authors><pubmed_authors>Kim J</pubmed_authors><pubmed_authors>Turgut A</pubmed_authors><pubmed_authors>Cao JJ</pubmed_authors><pubmed_authors>Malahfji M</pubmed_authors><pubmed_authors>Spetko N</pubmed_authors><pubmed_authors>Karagodin I</pubmed_authors><pubmed_authors>Cowan E</pubmed_authors><pubmed_authors>Wong TC</pubmed_authors><pubmed_authors>LaRocca G</pubmed_authors><pubmed_authors>Clark DE</pubmed_authors><pubmed_authors>Al-Tabatabaee S</pubmed_authors><pubmed_authors>Plein S</pubmed_authors><pubmed_authors>Azad MR</pubmed_authors><pubmed_authors>Rajewska-Tabor J</pubmed_authors><pubmed_authors>Cassar MP</pubmed_authors><pubmed_authors>Poenar AM</pubmed_authors><pubmed_authors>Gorecka M</pubmed_authors><pubmed_authors>Shah DJ</pubmed_authors><pubmed_authors>Neubauer S</pubmed_authors><pubmed_authors>Patel AR</pubmed_authors><pubmed_authors>Baldassarre LA</pubmed_authors><pubmed_authors>Kang Y</pubmed_authors><pubmed_authors>Reinhardt SW</pubmed_authors><pubmed_authors>Christia P</pubmed_authors><pubmed_authors>Chandrasekaran PS</pubmed_authors><pubmed_authors>Salerno M</pubmed_authors><pubmed_authors>Kelle S</pubmed_authors><pubmed_authors>Villa ADM</pubmed_authors><pubmed_authors>Chiribiri A</pubmed_authors><pubmed_authors>Tsao CW</pubmed_authors><pubmed_authors>Simonetti OP</pubmed_authors><pubmed_authors>Alvi N</pubmed_authors><pubmed_authors>Craft J</pubmed_authors><pubmed_authors>Doeblin P</pubmed_authors><pubmed_authors>Park C</pubmed_authors><pubmed_authors>Nambiar L</pubmed_authors><pubmed_authors>Hughes SG</pubmed_authors><pubmed_authors>Raman B</pubmed_authors></additional><is_claimable>false</is_claimable><name>Myocardial Injury on CMR in Patients With COVID-19 and Suspected Cardiac Involvement.</name><description>&lt;h4>Background&lt;/h4>Myocardial injury in patients with COVID-19 and suspected cardiac involvement is not well understood.&lt;h4>Objectives&lt;/h4>The purpose of this study was to characterize myocardial injury in a multicenter cohort of patients with COVID-19 and suspected cardiac involvement referred for cardiac magnetic resonance (CMR).&lt;h4>Methods&lt;/h4>This retrospective study consisted of 1,047 patients from 18 international sites with polymerase chain reaction-confirmed COVID-19 infection who underwent CMR. Myocardial injury was characterized as acute myocarditis, nonacute/nonischemic, acute ischemic, and nonacute/ischemic patterns on CMR.&lt;h4>Results&lt;/h4>In this cohort, 20.9% of patients had nonischemic injury patterns (acute myocarditis: 7.9%; nonacute/nonischemic: 13.0%), and 6.7% of patient</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 May</publication><modification>2025-04-19T14:16:36.535Z</modification><creation>2025-02-19T04:15:54.713Z</creation></dates><accession>S-EPMC9833283</accession><cross_references><pubmed>36752429</pubmed><doi>10.1016/j.jcmg.2022.10.021</doi></cross_references></HashMap>